Form 4: Climb Bio Director Thomas Stephen Basil Reports Stock Transactions
SEC Form 4 Filing
Director Thomas Stephen Basil reports the vesting and conversion of restricted stock units into Climb Bio common stock.
Summary
- On March 27, 2025, Thomas Stephen Basil, a director of Climb Bio, Inc., reported the vesting and conversion of 25,093 restricted stock units (RSUs) into common stock.
- This transaction increased his direct ownership of common stock to 179,188 shares.
- The RSUs were granted on June 27, 2024, and vested in installments, with the final 25% scheduled to vest on June 27, 2025, contingent upon continued service.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions, neither particularly positive nor negative.
Future Outlook
The remaining 25% of the RSUs will vest on June 27, 2025, subject to the Reporting Person's continued service.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock ownership.
Key Dates
| Date | Description |
|---|---|
| June 27, 2024 | Date the restricted stock units (RSUs) were granted. |
| January 1, 2025 | Date when 50% of the RSUs vested. |
| March 27, 2025 | Date of the reported transaction where 25,093 RSUs vested and were converted to common stock. |
| June 27, 2025 | Date when the remaining 25% of the RSUs are scheduled to vest. |
Keywords
Form 4, insider trading, restricted stock units, stock ownership, CLYM, Climb Bio, Thomas Stephen Basil
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.